RRM2 is a potential prognostic biomarker with functional significance in glioma
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 15 (3) , 533-543
Abstract
Glioma is one of the most common brain tumors, suggesting the importance of investigating the molecular mechanism of gliomas. We studied the roles of Ribonucleotide Reductase Regulatory Subunit M2 (RRM2) in glioma. Expressions of RRM2 are higher in glioma tissues evidenced by TCGA data, western blot and immunohistochemistry. RRM2 is negatively correlated with glioma patient's survival. RNA-seq showed that genes involved in apoptosis, proliferation, cell adhesion and negative regulation of signaling were up-regulated upon RNAi-mediated knock-down of RRM2. Cell phenotypes specific for stably knocking down RRM2 were determined using stable transfection in vitro. In an in vivo model, knock-down of RRM2 inhibited tumor growth and caused suppression of AKT and ERK1/2 signalings. Interfering RRM2 also down-regulated the expression of cyclin A, cyclin B1, cyclin D1, Vimentin, and N-cadherin, and elevated E-cadherin expression. Moreover, overexpression of RRM2 failed to increase the expression of cyclin B1, cyclin D1, and N-cadherin when phosphorylation of AKT and ERK1/2 was suppressed by LY294002 or PD98059. These findings indicated that RRM2 is a positive regulator of glioma progression which contributes to the migration and proliferation of glioma cells through ERK1/2 and AKT signalings and might be a novel prognostic indicator for glioma patients.Keywords
This publication has 42 references indexed in Scilit:
- Application of ggplot2 to Pharmacometric GraphicsCPT: Pharmacometrics & Systems Pharmacology, 2013
- GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq dataBioinformatics, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Thresholds of replication stress signaling in cancer development and treatmentNature Structural & Molecular Biology, 2012
- RNA sequencing: advances, challenges and opportunitiesNature Reviews Genetics, 2010
- Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histologyNeuro-Oncology, 2010
- Akt2 and Akt3 play a pivotal role in malignant gliomasNeuro-Oncology, 2009
- Traditional Chinese medicines in the treatment of hepatocellular cancers: a systematic review and meta-analysisJournal of Experimental & Clinical Cancer Research, 2009
- Ribonucleotide Reductases: Divergent Evolution of an Ancient EnzymeJournal of Molecular Evolution, 2002
- In vitro and in vivo evaluation of US-NCI compounds in human tumor xenograftsCancer Treatment Reviews, 1990